HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.

AbstractBACKGROUND:
Research comparing the survival of children with familial dilated cardiomyopathy (FDCM) to that of children with idiopathic dilated cardiomyopathy (IDCM) has produced conflicting results.
METHODS AND RESULTS:
We analyzed data from children with FDCM or IDCM using the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry. Compared to children with IDCM (n=647), children with FDCM (n=223) were older (mean 6.2 versus 4.5 years, P<0.001), less often had heart failure (64% versus 78%, P<0.001), had less-depressed mean left ventricular fractional shortening z scores (-7.85±3.98 versus -9.06±3.89, P<0.001) and lower end-diastolic dimension z scores (4.12±2.61 versus 4.91±2.57, P<0.001) at diagnosis. The cumulative incidence of death was lower for patients with FDCM compared with IDCM (P=0.04; hazard ratio 0.64, P=0.06), but no difference in risk of transplant or the combined death or transplant outcome. There was no difference in the proportion of children with echocardiographic normalization at 3 years of follow-up (FDCM, 30% versus IDCM, 26%; P=0.33). Multivariable analysis showed no difference in outcomes between FDCM and IDCM but for both groups older age, congestive heart failure, and increased left ventricular end-systolic dimension zscore at diagnosis were independently associated with an increased risk of death or heart transplantation (all Ps<0.001).
CONCLUSIONS:
There was no survival difference between FDCM and IDCM after adjustment for other factors. Older age, congestive heart failure, and greater left ventricular dilation at diagnosis were independently associated with increased risk of the combined end point of death or transplantation.
CLINICAL TRIAL REGISTRATION:
URL: https://clinicaltrials.gov. Unique identifier: NCT00005391.
AuthorsPaolo Rusconi, James D Wilkinson, Lynn A Sleeper, Minmin Lu, Gerald F Cox, Jeffrey A Towbin, Steven D Colan, Steven A Webber, Charles E Canter, Stephanie M Ware, Daphne T Hsu, Wendy K Chung, John L Jefferies, Christina Cordero, Steven E Lipshultz, Pediatric Cardiomyopathy Registry Investigators
JournalCirculation. Heart failure (Circ Heart Fail) Vol. 10 Issue 2 (Feb 2017) ISSN: 1941-3297 [Electronic] United States
PMID28193717 (Publication Type: Comparative Study, Journal Article, Multicenter Study)
Copyright© 2017 American Heart Association, Inc.
Topics
  • Age Factors
  • Canada (epidemiology)
  • Cardiomyopathy, Dilated (diagnostic imaging, mortality, therapy)
  • Child
  • Child, Preschool
  • Disease-Free Survival
  • Echocardiography
  • Female
  • Heart Failure (diagnostic imaging, mortality, therapy)
  • Heart Transplantation
  • Humans
  • Hypertrophy, Left Ventricular (diagnostic imaging, mortality, therapy)
  • Incidence
  • Infant
  • Kaplan-Meier Estimate
  • Longitudinal Studies
  • Male
  • Multivariate Analysis
  • Myocardial Contraction
  • National Heart, Lung, and Blood Institute (U.S.)
  • Proportional Hazards Models
  • Registries
  • Risk Factors
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • United States (epidemiology)
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: